Journal Mobile Options
Table of Contents
Vol. 41, No. 6, 2005
Issue release date: November–December 2005
Pediatr Neurosurg 2005;41:323–327

Primary Endovascular Therapy with Clot Retrieval and Balloon Angioplasty for Acute Basilar Artery Occlusion

Zaidat O.O. · Tolbert M. · Smith T.P. · Alexander M.J.
Divisions of aInterventional Neuroradiology and bNeurosurgery, Duke University Medical Center, Durham, N.C., USA

Individual Users: Register with Karger Login Information

Please create your User ID & Password

Contact Information

I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in


This case report demonstrates that mechanical clot disruption and retrieval may be performed safely and successfully in a child with basilar artery (BA) thrombosis. A 16-year-old boy presented to our institution with locked-in syndrome 20 h after symptom onset. Brain MRI and cerebral angiography findings were consistent with BA occlusion. The child underwent endovascular therapy with clot retrieval followed by balloon angioplasty achieving immediate recanalization and clinical recovery on 3-month follow-up. This case highlights the use of primary neurointerventional devices in children with BA occlusion presenting beyond the conventional therapeutic window for other interventions.

Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.


  1. Gobin YP, Starkman S, Duckwiler GR, Grobelny T, Kidwell CS, Jahan R, Pile-Spellman J, Segal A, Vinuela F, Saver JL: MERCI 1: A phase 1 study of mechanical embolus removal in cerebral ischemia. Stroke 2004;35:2848–2854.
  2. Mayer TE, Hamann GF, Brueckmann HJ: Treatment of basilar artery embolism with a mechanical extraction device: Necessity of flow reversal. Stroke 2002;33:2232–2235.
  3. Leary MC, Saver JL, Gobin YP, Jahan R, Duckwiler GR, Vinuela F, Kidwell CS, Frazee J, Starkman S: Beyond tissue plasminogen activator: Mechanical intervention in acute stroke. Ann Emerg Med 2003;41:838–846.
  4. Kerber CW, Barr JD, Berger RM, Chopko BW: Snare retrieval of intracranial thrombus in patients with acute stroke. J Vasc Interv Radiol 2002;13:1269–1274.
  5. Nedeltchev K, Remonda L, Do DD, Brekenfeld C, Ozdoba C, Arnold M, Mattle HP, Schroth G: Acute stenting and thromboaspiration in basilar artery occlusions due to embolism from the dominating vertebral artery. Neuroradiology 2004;46:686–691.
  6. NINDS rt-TPA Stroke Study Group: Tissue plasminogen activator for acute ischemic stroke. N Engl J Med1995;333:1581–1587.
  7. Suarez JI, Zaidat OO, Sunshine JL, Tarr R, Selman WR, Landis DM: Endovascular administration after intravenous infusion of thrombolytic agents for the treatment of patients with acute ischemic strokes. Neurosurgery 2002;50:251–260.
  8. Brandt T, Pessin MS, Kwan ES, Caplan LR: Survival with basilar artery occlusion. Cerebrovasc Dis 1995;5:182–187.

    External Resources

  9. Arnold M, Nedeltchev K, Schroth G, Baumgartner RW, Remonda L, Loher TJ, Stepper F, Sturzenegger M, Schuknecht B, Mattle HP: Clinical and radiological predictors of recanalization and outcome of 40 patients with acute basilar artery occlusion treated with intra-arterial thrombolysis. J Neurol Neurosurg Psychiatry 2004;75:857–862.
  10. Stapf C, Marshall R, Mohr JP, Duong HD, Brunson JC, Benson RT, Mast H: Late intra-arterial thrombolysis. Eur J Med Res 2000;5:303–306.
  11. Brandt T: Diagnosis and thrombolytic therapy of acute basilar artery occlusion: A review. Clin Exp Hypertens 2002;24:611–622.
  12. Cross DT III, Moran CJ, Akins PT, Angtuaco EE, Derdeyn CP, Diringer MN: Collateral circulation and outcome after basilar artery thrombolysis. AJNR Am J Neuroradiol1998;19:1557–1563.
  13. Eckert B, Koch C, Thomalla G, RoetherJ, Zeumer H: Acute basilar artery occlusion treated with combined intravenous Abciximab and intra-arterial tissue plasminogen activator: Report of 3 cases. Stroke 2002;33:1424–1427.
  14. Nakayama T, Tanaka K, Kaneko M, Yokoyama T, Uemura K: Thrombolysis and angioplasty for acute occlusion of intracranial vertebrobasilar arteries. Report of three cases. J Neurosurg 1998;88:919–922.

Pay-per-View Options
Direct payment This item at the regular price: USD 38.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 26.50